Alpha9 Theranostics
Alpha9 Theranostics
Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.
About
What does Alpha9 Theranostics do?
Alpha9 Theranostics is a biotechnology company focused on the development of next-generation radiopharmaceuticals for the diagnosis and treatment of cancer. They leverage their expertise in molecular imaging and targeted delivery to create innovative theranostic agents that can precisely identify and eliminate cancer cells.
What is Alpha9 Theranostics's revenue?
StartupHub estimates Alpha9 Theranostics's annual revenue at $1.9M (range $597K to $6.0M, 31% confidence), based on comparable companies in the sector.
What is Alpha9 Theranostics's valuation?
StartupHub estimates Alpha9 Theranostics's effective valuation at $38.8M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Alpha9 Theranostics raised?
Alpha9 Theranostics has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Alpha9 Theranostics headquartered?
Alpha9 Theranostics is headquartered in Vancouver, Canada.
When was Alpha9 Theranostics founded?
Alpha9 Theranostics was founded in 2017.
What industry does Alpha9 Theranostics operate in?
Alpha9 Theranostics operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Radiopharmaceuticals.
What is Alpha9 Theranostics's current status?
Alpha9 Theranostics's current operating status is: Inactive.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.